List view / Grid view

Thomas Breuer

Filter the results

 

news

GSK receives positive CHMP opinion for Cervarix™ two-dose schedule

GSK announced that the European Medicines Agency's Committee for Medicinal…

28 November 2013 | By GlaxoSmithKline

GSK announced that the European Medicines Agency's Committee for Medicinal Products for Human Use is recommending marketing authorisation for a two-dose schedule in 9-14 year old girls for its cervical cancer vaccine, Cervarix™...